Analysts Set Expectations for BIOX FY2025 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Investment analysts at Brookline Capital Management raised their FY2025 earnings estimates for Bioceres Crop Solutions in a note issued to investors on Wednesday, May 21st. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings of $0.04 per share for the year, up from their prior forecast of $0.02. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions' FY2026 earnings at $0.21 EPS, FY2027 earnings at $0.41 EPS and FY2028 earnings at $0.56 EPS.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its earnings results on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.08. The business had revenue of $59.60 million for the quarter, compared to the consensus estimate of $61.80 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%.

Other research analysts also recently issued research reports about the stock. Lake Street Capital reduced their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Finally, Oppenheimer cut their price target on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 22nd. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $8.63.

Bioceres Crop Solutions Price Performance

Bioceres Crop Solutions stock traded up $0.53 on Monday, reaching $5.16. The company's stock had a trading volume of 298,568 shares, compared to its average volume of 173,606. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33. The company has a market cap of $323.59 million, a price-to-earnings ratio of 258.13 and a beta of 0.40. The business's fifty day moving average price is $4.35 and its 200 day moving average price is $5.45. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.86.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently bought and sold shares of BIOX. Jones Financial Companies Lllp raised its holdings in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after acquiring an additional 5,339 shares during the period. Bank of America Corp DE increased its stake in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares during the last quarter. Jump Financial LLC acquired a new stake in Bioceres Crop Solutions in the 4th quarter valued at $72,000. Avanza Fonder AB acquired a new stake in Bioceres Crop Solutions in the 1st quarter valued at $72,000. Finally, PDT Partners LLC acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $81,000. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.